Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: In vitro, stability, and antifungal activities assessment

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Pawar, Pravin ^a   Kashyap, Heena ^a   Malhotra, Sakshi ^a   Sindhu, Rakesh ^a  

^a CHITKARA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALGINIC ACID; POLOXAMER; VORICONAZOLE; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; ANTIFUNGAL AGENT; BETA CYCLODEXTRIN DERIVATIVE; GEL; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CHEMICAL REACTION; COLD METHOD TECHNIQUE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; GELATION; GELATION TEMPERATURE; IN SITU GELLING SYSTEM; IN VITRO STUDY; MUCOADHESION; MUCOADHESIVE STRENGTH; MYCOSIS; NONHUMAN; PHARMACEUTICAL ENGINEERING; PHYSICAL CHEMISTRY; SHELF LIFE; SOL TO GEL TRANSITION; TEMPERATURE; TEMPERATURE DEPENDENCE; VISCOSITY; ADHESION; ANIMAL; CHEMISTRY; CORNEA; DRUG EFFECTS; EYE; FLOW KINETICS; GEL; GOAT; KINETICS; MICROBIAL SENSITIVITY TEST; PERMEABILITY; PH; DRUG EFFECT;

CANDIDA ALBICANS;

ADHESIVENESS; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; BETA-CYCLODEXTRINS; CANDIDA ALBICANS; CORNEA; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EYE; GELS; GOATS; HYDROGEN-ION CONCENTRATION; IN VITRO TECHNIQUES; KINETICS; MICROBIAL SENSITIVITY TESTS; PERMEABILITY; PYRIMIDINES; RHEOLOGY; TEMPERATURE; TRIAZOLES; VISCOSITY; VORICONAZOLE;

EID: 84878687363     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/341218     Document Type: Article

References (42)

1. Saettone M. F., Giannaccini B., Guiducci A., Marca F., Tota G., Polymer effects on ocular bioavailability, II: the influence of benzalkonium chloride on the mydriatic response of tropicamide in different polymeric vehicles. Int J Pharm 1985 25 73 83
2. Shell J. W., Ocular drug delivery systems-a review. Cutaneous and Ocular Toxicol 1982 1 49 63
3. Robinson J. R., Ocular drug delivery: mechanisms of corneal drug transport & mucoadhesive delivery systems. STP Pharma 1989 12 839 846
4. Le Bourlais C., Acar L., Zia H., Sado P. A., Needham T., Leverge R., Ophthalmic drug delivery systems-recent advances. Progress in Retinal and Eye Research 1998 17 1 33 58 2-s2.0-0031965225 10.1016/S1350-9462(97)00002-5 (Pubitemid 28040752)
5. Patton T. F., Robinson J. R., Ocular evaluation of polyvinyl alcohol vehicle in rabbits. Journal of Pharmaceutical Sciences 1975 64 8 1312 1316 2-s2.0-0016774215
6. Sattone M. F., Ginnaccini B., Tenzggi A., Tellini P. N., Vehicle effect on ophthalmic bioavailibility: the influence of different polymers on the activity of pilocarpine in rabbits and man. Journal of Pharmacy and Pharmacology 1982 34 464 466
7. Hui H. W., Robinson J. R., Ocular delivery of progesterone using a bioadhesive polymer. International Journal of Pharmaceutics 1985 26 3 203 213 2-s2.0-0022399293 (Pubitemid 16228619)
8. Gunny R. H., Ibrahim A. A., Duri P., Wilson C. G., Washington N., Design and evaluation of controlled release system for the eye. Journal of Controlled Release 1987 6 367 373 (Pubitemid 18019091)
9. Ding S., Recent developments in ophthalmic drug delivery. Pharmaceutical Science & Technology Today 1998 1 328 3235
10. Taravella M. J., Collagen shield delivery of ofloxacin to the human eye. Journal of Cataract and Refractive Surgery 1999 25 4 562 565 2-s2.0-0032910844 (Pubitemid 29173471)
11. Séchoy O., Tissié G., Sébastian C., Maurin F., Driot J. Y., Trinquand C., A new long acting ophthalmic formulation of Carteolol containing alginic acid. International Journal of Pharmaceutics 2000 207 1-2 109 116 2-s2.0-0034633895 10.1016/S0378-5173(00)00539-1
12. Peppas N. A., Bures P., Leobandung W., Ichikawa H., Hydrogels in pharmaceutical formulations. European Journal of Pharmaceutics and Biopharmaceutics 2000 50 27 46 (Pubitemid 30326687)
13. Bromberg L. E., Ron E. S., Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Advanced Drug Delivery Reviews 1998 31 3 197 221 2-s2.0-0032482152 10.1016/S0169-409X(97)00121-X (Pubitemid 28191866)
14. Soppimath K. S., Aminabhavi T. M., Dave A. M., Kumbar S. G., Rudzinski W. E., Stimulus-responsive smart hydrogels as novel drug delivery systems. Drug Development and Industrial Pharmacy 2002 28 8 957 974 2-s2.0-0036386083 10.1081/DDC-120006428
15. Ritter Jones M., Messersmith P. B., In situ forming biomaterials. Oral and Maxillofacial Surgery Clinics of North America 2002 14 1 29 38 2-s2.0-0036339407 10.1016/S1042-3699(02)00015-8
16. Bhardwaj T. R., Kanwar M., Lal R., Gupta A., Natural gums and modified natural gums as sustained-release carriers. Drug Development and Industrial Pharmacy 2000 26 10 1025 1038 2-s2.0-0033801080 10.1081/DDC-100100266
17. Guo J. H., Skinner G. W., Harcum W. W., Barnum P. E., Pharmaceutical applications of naturally occurring water-soluble polymers. Pharmaceutical Science and Technology Today 1998 1 6 254 261 2-s2.0-0032171022 10.1016/S1461-5347(98)00072-8 (Pubitemid 28439297)
18. Schmolka I. R., A review of block polymer surfactants. Journal of the American Oil Chemists' Society 1977 54 3 110 116 2-s2.0-36048950697 10.1007/BF02894385
19. Gilbert J. C., Richardson J. L., Davies M. C., Palin K. J., Hadgraft J., The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. Journal of Controlled Release 1987 5 2 113 118 2-s2.0-0000432372
20. Choi H. G., Jung J. H., Ryu J. M., Yoon S. J., Oh Y. K., Kim C. K., Development of In situ -gelling and mucoadhesive acetaminophen liquid suppository. International Journal of Pharmaceutics 1998 165 1 33 44 2-s2.0-0032550314 10.1016/S0378-5173(97)00386-4 (Pubitemid 28218342)
21. Prajna N. V., Mascarenhas J., Krishnan T., Reddy P. R., Prajna L., Srinivasan M., Vaitilingam C. M., Hong K. C., Lee S. M., McLeod S. D., Zegans M. E., Porco T. C., Lietman T. M., Acharya N. R., Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Archives of Ophthalmology 2010 128 6 672 678 2-s2.0-77953623941 10.1001/archophthalmol.2010.102
22. Hariprasad S. M., Mieler W. F., Lin T. K., Sponsel W. E., Graybill J. R., Voriconazole in the treatment of fungal eye infections: a review of current literature. British Journal of Ophthalmology 2008 92 7 871 878 2-s2.0-47049088124 10.1136/bjo.2007.136515 (Pubitemid 351969658)
23. Davies N., Biopharmaceutical considerations in topical ocular drug delivery. Clinical and Experimental Pharmacology and Physiology 2000 27 558 562 (Pubitemid 30418006)
24. Dupuis A., Tournier N., Le Moal G., Venisse N., Preparation and stability of voriconazole eye drop solution. Antimicrobial Agents and Chemotherapy 2009 53 2 798 799 2-s2.0-59749088785 10.1128/AAC.01126-08
25. Halim Mohamed M. A., Mahmoud A. A., Formulation of indomethacin eye drops via complexation with cyclodextrins. Current Eye Research 2011 36 3 208 216 2-s2.0-79951815031 10.3109/02713683.2010.536294
26. Nijhawan R., Agarwal S. P., Development of an ophthalmic formulation containing ciprofloxacin-hydroxypropyl-b-cyclodextrin complex. Bollettino Chimico Farmaceutico 2003 142 5 214 219 2-s2.0-0141756238 (Pubitemid 37210363)
27. Klont R. R., Eggink C. A., Rijs A. J., Wesseling P., Verweij P. E., Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clinical Infectious Diseases 2005 40 12 110 112 2-s2.0-29944440919
28. Singhare D. S., Khan S., Yeole P. G., Temperature induced In situ gel of lidocaine hydrochloride for periodontal anaesthsia. Indian Drugs 2005 42 8 519 524 2-s2.0-77954673962
29. Shastri D., Prajapati S., Patel L., Thermoreversible mucoadhesive ophthalmic In situ hydrogel: design and optimization using a combination of polymers. Acta Pharmaceutica 2010 60 3 349 360 2-s2.0-78650079930 10.2478/v10007-010-0029-4
30. Hassan E. E., Gallo J. M., A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharmaceutical Research 1990 7 5 491 495 2-s2.0-0025108791 (Pubitemid 20322199)
31. Costa P., Lobo S. M. J., Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences 2001 13 123 133 (Pubitemid 32288781)
32. Pathak M. K., Chhabra G., Pathak K., Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing. Drug Development and Industrial Pharmacy 2013 39 5 780 790 10.3109/03639045.2012. 707203
33. Bauer H. W., Kirby W. M. M., Slerris J. C., Truck M., Antibiotic susceptibility testing by a standardized single disc method. American Journal of Clinical Pathology 1996 45 493 496
34. Q1A (R2): stability testing of new drug substances and products. Proceedings of the International Conference on Harmonization (ICH '03) 2003 Geneva, Switzerland
35. Edsman K., Carlfors J., Petersson R., Rheological evaluation of poloxamer as an In situ gel for ophthalmic use. European Journal of Pharmaceutical Sciences 1998 6 2 105 112 2-s2.0-0032055148 10.1016/S0928-0987(97)00075-4 (Pubitemid 28164280)
36. Wei G., Xu H., Ding P. T., Li S. M., Zheng J. M., Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. Journal of Controlled Release 2002 83 1 65 74 2-s2.0-0037130557 10.1016/S0168-3659(02)00175-X (Pubitemid 35239815)
37. Smart J. D., Kellaway I. W., Worthington H. E. C., An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. Journal of Pharmacy and Pharmacology 1984 36 5 295 299 2-s2.0-0021236615 (Pubitemid 14101358)
38. Kim E. Y., Gao Z. G., Park J. S., Li H., Han K., rhEGF/HP- β -CD complex in poloxamer gel for ophthalmic delivery. International Journal of Pharmaceutics 2002 233 1-2 159 167 2-s2.0-0037148668 10.1016/S0378-5173(01) 00933-4 (Pubitemid 34230428)
39. Qi H., Li L., Huang C., Li W., Wu C., Optimization and physicochemical characterization of thermosensitive poloxamer gel containing puerarin for ophthalmic use. Chemical and Pharmaceutical Bulletin 2006 54 11 1500 1507 2-s2.0-33750705273 10.1248/cpb.54.1500 (Pubitemid 44703975)
40. Smart J. D., Kellaway I. W., Worthington H. E. C., An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. Journal of Pharmacy and Pharmacology 1984 36 5 295 299 2-s2.0-0021236615 (Pubitemid 14101358)
41. Liu Z., Li J., Nie S., Liu H., Ding P., Pan W., Study of an alginate/HPMC-based In situ gelling ophthalmic delivery system for gatifloxacin. International Journal of Pharmaceutics 2006 315 1-2 12 17 2-s2.0-33646366411 10.1016/j.mrfmmm.2005.10.015 (Pubitemid 43674115)
42. Maurice D. M., Riley M. V., Ocular Pharmacokinetics. Biochemistry of the Eye 1970 London, UK Graymore 6 16